1 – 10 of 33
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Direct comparison of two extended half-life PEGylated recombinant FVIII products : a randomized, crossover pharmacokinetic study in patients with severe hemophilia A (
- 2019
- Direct comparison of two extended-half-life recombinant FVIII products : a randomized, crossover pharmacokinetic study in patients with severe hemophilia A (
- 2017
- Comparative burden of arthropathy in mild haemophilia : a register-based study in Sweden (
- Effect of late prophylaxis in hemophilia on joint status : A randomized trial (
- Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients : Results of the INSIGHT case-control study (
- 2016
- Aspects of prophylactic treatment of hemophilia (
- Does the intensity and quality of treatment and not only the factor VIII level influence global hemostasis in patients with hemophilia A? (
- Prophylaxis for Hemophilia in the Era of Extended Half-Life Factor VIII/Factor IX Products (
- 2014
- Factor VIII therapy for hemophilia A: current and future issues (
- The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A (